Kainos Group plc Director/PDMR Shareholding (9791J)

TIDMKNOS

RNS Number : 9791J

Kainos Group plc

03 July 2017

03 July 2017

Kainos Group plc

("Kainos" or the "Company)

Director / PDMR shareholdings

The Company has been notified that on 03 July 2017, Paul Gannon, Director, sold 300,000 shares in the Company at an average price of 271.75p.

Following this notification, Paul Gannon and his Connected Person have a reportable shareholding of 8,831,240 ordinary shares in the issued share capital of the Company, constituting 7.5% of the issued share capital of the Company.

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial responsibilities 
       / person closely associated 
---  ----------------------------------------------------------------- 
 a.   Name                            Paul Gannon 
---  ------------------------------  --------------------------------- 
 2.   Reason for the notification 
---  ----------------------------------------------------------------- 
 a.   Position/status                 Sales Director 
---  ------------------------------  --------------------------------- 
 b.   Initial notification            Initial 
       /Amendment 
---  ------------------------------  --------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
---  ----------------------------------------------------------------- 
 a.   Name                            Kainos Group plc 
---  ------------------------------  --------------------------------- 
 b.   LEI                             213800H2PQMIF3OVZY47 
---  ------------------------------  --------------------------------- 
 4.   Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
---  ----------------------------------------------------------------- 
 a.   Description of                  Ordinary Shares of GBP0.005 each 
       the 
       Financial instrument/ 
       type of instrument              KNOS 
       Identification 
       code 
---  ------------------------------  --------------------------------- 
 b.   Nature of the transaction       Disposal of Shares 
---  ------------------------------  --------------------------------- 
 c.   Price(s) and volume(s)           Price(s)    Volume(s) 
                                       ----------  ---------- 
                                        GBP2.71     300,000 
                                       ----------  ---------- 
---  ------------------------------  --------------------------------- 
 d.        Aggregated information 
             *    Aggregated volume     N/A 
 
 
             *    Price 
---  ------------------------------  --------------------------------- 
 e.   Date of the transaction         2017-06-30 
---  ------------------------------  --------------------------------- 
 f.   Place of the transaction        LSE - Regulated Market - XLON 
---  ------------------------------  --------------------------------- 
 

Ends

For further information, please contact:

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Brian Gannon, SVP Corporate Development

Investec Bank plc [phone]

Patrick Robb / Dominic Emery

Canaccord Genuity [phone]

Simon Bridges / Emma Gabriel

FTI Consulting LLP [phone]

Matt Dixon / Nicola Krafft

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the largest boutique partner for Workday Inc. ('Workday') in Europe, responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.

Kainos employs approximately 1,000 staff and contractors across eight offices in Europe and the USA, working interchangeably across its Services and Platforms businesses.

Kainos is listed on the London Stock Exchange (KNOS). For further information, please visit www.kainos.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHOKNDBPBKDPOK

(END) Dow Jones Newswires

July 03, 2017 11:30 ET (15:30 GMT)